The Utility of Whole Exome Sequencing in Fetuses With Isolated Increased Nuchal Translucency
Molecular Genetics & Genomic Medicine · 2025
DOI: 10.1002/mgg3.70161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Hui Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maternal-Fetal Medicine Centre, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Nuchal Translucency Measurement, Exome Sequencing, Prenatal Diagnosis. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
Background
To evaluate the utility of prenatal whole exome sequencing (WES) in cases of isolated increased nuchal translucency (NT).
Methods
Retrospective analysis of the prenatal WES results in fetuses with increased NT (≥ 3.0 mm) and normal fetal anatomy, normal karyotype, and chromosomal microarray analysis (CMA). Subgroup analysis was performed based on NT measurements.
Results
Diagnostic variants were identified in 3 of 118 fetuses (2.5%) with isolated increased NT (≥ 3.0 mm). The distribution of positive findings was as follows: NT 3.0–3.4 mm group ( n = 13): 1 case (7.7%) with diagnostic genetic variants; NT ≥ 3.5 mm group ( n = 105): 2 cases (1.9%) with diagnostic genetic variants (both in the NT 5.0–6.4 mm subgroup). Fisher's exact test (two‐tailed) showed no statistically significant differences in diagnostic yield between: NT 3.0–3.4 mm versus NT ≥ 3.5 mm ( p = 0.298); NT 3.0–3.4 mm versus NT 5.0–6.4 mm ( p = 1.000); NT ≥ 3.0 mm versus NT ≥ 3.5 mm ( p = 1.000).
Conclusion
Our analysis revealed a low diagnostic yield (2.5%) for prenatal WES in cases of isolated increased NT ≥ 3.0 mm. Our findings provide valuable evidence for clinical counseling, particularly when patients inquire about the likelihood of isolated findings. These data offer meaningful guidance for their decision‐making process regarding further testing options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Maternal-Fetal Medicine Centre, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China.
- Medical Genetics Centre, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China.
ORCID-Profile: Hui Wang, Caiqun Luo, Yang Liu
Förderung
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Wang, H., Luo, C., Geng, Q., Xu, X., & Liu, Y. (2025). The Utility of Whole Exome Sequencing in Fetuses With Isolated Increased Nuchal Translucency. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70161
Vancouver
Wang H, Luo C, Geng Q, Xu X, Liu Y. The Utility of Whole Exome Sequencing in Fetuses With Isolated Increased Nuchal Translucency. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70161
BibTeX
@article{Wang2025,
author = {Wang, Hui and Luo, Caiqun and Geng, Qian and Xu, Xiaoxin and Liu, Yang},
title = {The Utility of Whole Exome Sequencing in Fetuses With Isolated Increased Nuchal Translucency},
journal = {Molecular Genetics & Genomic Medicine},
year = {2025},
doi = {10.1002/mgg3.70161}
}
EUVIMED